Proteolytic processing and particle maturation

Current Topics in Microbiology and Immunology

Volumn 214, Issue , 1996, Pages 95-131

  Vogt, V M ^a  

^a Department of Population Medicine and Diagnostic Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE; VIRUS ENZYME;

ENZYME CONFORMATION; ENZYME SPECIFICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; RETROVIRUS; REVIEW;

LENTIVIRUS; PRIMATES; SPUMAVIRUS; UNIDENTIFIED RETROVIRUS;

EID: 0030419901     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-80145-7_4     Document Type: Review

References (154)

1. Abdel-Meguid SS, Zhao B, Murthy KHM, Winborne E, Choi JK, Desjarlais RL, Minnich MD, Culp JS, Debouck D, Tomaszek TA Jr, et al (1993) Inhibition of human immunodeficiency virus-1 protease by a c-2- symmetric phosphinate Synthesis and crystallographic analysis. Biochemistry 32 7972-7980
2. Ainsztein AM, Purich DL (1992) Cleavage of bovine brain microtubule associated protein-2 by human immunodeficiency virus proteinase J Neurochem 59: 874-880
3. Babé LM, Rosé J, Craik CS (1992) Synthetic "interface" peptides alter dimeric assembly of the HIV 1 and 2 proteases. Protein Sci 1: 1244-1253
4. Bennett RP, Rhee S, Craven RC, Hunter E, Wills JW (1991) Amino acids encoded downstream of Gag are not required by Rous sarcoma virus protease during Gag-mediated assembly. J Virol 65: 272-280
5. Berkowitz RD, Ohagen A, Höglund S, Goff SP (1995) Retroviral nucleocapsid domains mediate the specific recognition of genomic viral RNAs by chimeric Gag polyproteins during RNA packaging in vivo. J Virol 69: 6445-6456
6. Boutelje J, Karlstrom AR, Hartmanis MGN, Holmgren E, Sjogren A, Levine RL (1990) Human immunodeficiency viral protease is catalytically active as a fusion protein: characterization of the fusion and native enzymes produced in Escherichia coli Arch Biochem Biophys 283: 141-149
7. Bowles N, Bonnet D, Mulhauser F, Spahr PF (1994) Site-directed mutagenesis of the P2 region of the Rous sarcoma virus Gag gene: effects on Gag polyprotein processing. Virology 203: 20-28
8. Brody BA, Rhee SS, Sommerfelt MA, Hunter E (1992) A viral protease-mediated cleavage of the transmembrane glycoprotein of Mason-Pfizer monkey virus can be suppressed by mutations within the matrix protein. Proc Natl Acad Sci USA 89: 3443-3447
9. Brody BA, Rhee SS, Hunter E (1994) Postassembly cleavage of a retroviral glycoprotein cytoplasmic domain removes a necessary incorporation signal and activates fusion activity. J Virol 68: 4620-4627
10. Bryant M, Ratner L (1990) Myristoylation-dependent replication and assembly of human immunodeficiency virus 1 Proc Natl Acad Sci USA 87: 523-527
11. Burstein H, Bizub D, Skalka AM (1991) Assembly and processing of avian retroviral gag polyproteins containing linked protease dimers. J Virol 65: 6165-6172
12. Burstein H, Bizyb D, Kotler M, Schatz G, Vogt VM, Skalka AM (1992) Processing of avian retroviral Gag polyprotein precursors is blocked by a mutation in the NC-PR cleavage site. J Virol 66: 1781-1785
13. Cameron CE, Grinde B, Jentoft J, Leis J, Weber IT, Copeland TD, Wlodawer A (1992) Mechanism of inhibition of the retroviral protease by a Rous sarcoma virus peptide substrate representing the cleavage site between the Gag P2 and P10 proteins J Biol Chem 267: 23735-23741
14. Cameron CE, Ridky TW, Shulenin S, Leis J, Weber IT, Copeland T, Wlodawer A, Burstein H, Bizub-Bender D, Skalka AM (1994) Mutational analysis of the substrate binding pocket of the Rous sarcoma virus and human immunodeficiency virus-1 protease. J Biol Chem 269: 11170-11177
15. Chou JJ (1993) A vectorized sequence-coupling model for predicting HIV protease cleavage sites in proteins J Biol Chem 268: 16938-16948
16. Co E, Koelsch G, Lin Y, Ido E, Hartsuck JA, Tang J (1994) Proteolytic processing mechanisms of a miniprecursor of the aspartic protease of human immunodeficiency virus type 1. Biochemistry 33: 1248-1254
17. Craven RC, Bennett RP, Wills JW (1991) Role of the avian retroviral protease in the activation of reverse transcriptase during virion assembly J Virol 65. 6205-6217
18. Craven RC, Leure-duPree AE, Erdie CR, Wilson CB, Wills JW (1993) Necessity of the spacer peptide between CA and NC in the Rous sarcoma virus Gag protein. J Virol 67: 6246-6252
19. Crawford S, Goff SP (1985) A deletion mutation in the 5′ part of the pol gene of Moloney murine leukemia virus blocks proteolytic processing of the gag and pol polyproteins. J Virol 53 899-907
20. Darke PL (1994) Stability of dimeric retroviral proteases. In: Kuo LC, Shafer JA (eds) Retroviral proteases. Academic, New York, pp 104-127 (Methods in enzymology, vol 241)
21. Darke PL, Jordan SP, Hall DL, Zugay JA, Shafer JA, Kuo LC (1994) Dissociation and association of the HIV-1 protease dimer subunits: equilibria and rates. Biochemistry 33: 98-105
22. Davies DR (1990) The structure and function of the aspartic proteinases Annu Rev Biophys Chem 19 189-215
23. Debouck C (1992) The HIV-1 protease as a therapeutic target of AIDS AIDS Res Hum Retroviruses 8: 153-164
24. Desjarlais RL, Seibel GL, Kuntz ID, Furth PS, Alvarez JC, Ortiz de Montellano PR, Decamp DL, Babé LM, Craik CS (1990) Structure-based design of nonpeptide inhibitors specific for the human immunodeficiency virus 1 protease. Proc Natl Acad Sci USA 87: 6644-6648
25. Divita G, Rittinger K, Geourjon C, Deléage G, Goody RS (1995) Dimerization kinetics of HIV-1 and HIV-2 reverse transcriptase a two step process J Mol Biol 245: 508-521
26. Dougherty WG, Semler BL (1993) Expression of virus-encoded proteinases: functional and structural similarities with cellular enzymes Microbiol Rev 57 781-822
27. Dunn DM, Gustchina A, Wlodawer A, Kay J (1994). Subsite preferences of retroviral proteases In. Kuo LC, Shafer JA (eds) Retroviral proteases. Academic, New York, pp 254-278 (Methods in enzymology, vol 241)
28. Eisenman R, Vogt VM (1978) The biosynthesis of oncovirus proteins. Biochim Biophys Acta (Cancer Rev) 473: 187-239
29. Eisenman RN, Mason WS, Linial M (1980) Synthesis and processing of polymerase proteins of wild type and mutant avian retroviruses. J Virol 36. 89-104
30. Erickson-Viitanen S, Manfredi J, Viitanen P, Tribe DE, Tritch R, Hutchison CA III, Loeb DD, Swanstrom R (1989) Cleavage of HIV-1 Gag polyprotein synthesized in-vitro Sequential cleavage by the viral protease AIDS Res Hum Retroviruses 5: 577-592
31. Fäcke M, Janetzko A, Shoeman RL, Kräusslich HG (1993) A large deletion in the matrix domain of the human immunodeficiency virus Gag gene redirects virus particle assembly from the plasma membrane to the endoplasmic reticulum J Virol 67: 4972-4980
32. Freund J, Kellner R, Konvalinka J, Wolber V, Kräusslich H-G, Kalbitzer HR (1994) A possible regulation of negative factor (Nef) activity of human immunodeficiency virus type 1 by the viral protease. Eur J Biochem 223. 589-593
33. Fitzgerald PMD, Springer JE (1991) Structure and function of retroviral proteases. Annu Rev Biophys Chem 20: 299-320
34. Fu W, Rein A (1993) Maturation of dimeric viral RNA of Moloney murine leukemia virus J Virol 67 5443-5449
35. Fu W, Gorelick RJ, Rein A (1994) Characterization of human immunodeficiency virus type 1 dimeric RNA from wild-type and protease-defective virions. J Virol 68: 5013-5018
36. Gelderblom HR (1991) Assembly and morphology of HIV. potential effect of structure on viral function AIDS 5 617-638
37. Göttlinger HG, Sodroski JG, Haseltine WA (1989) Role of capsid presursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc Natl Acad Sci USA 86. 5781-5785
38. Griffiths JT, Phylip LH, Konvalinka J, Strop P, Gustchina A, Wlodawer A, Davenport RJ, Briggs R, Dunn BM, Kay J (1992) Different requirements for productive interaction between the active site of HIV-1 proteinase and substrates containing hydrophobic or aromatic pro cleavage sites. Biochemistry 31: 5193-5200
39. Grinde B, Cameron CE, Lets J, Weber IT, Wlodawer A, Burstein H, Skalka AM (1992) Analysis of substrate interactions of the Rous sarcoma virus wild type and mutant proteases and human immunodeficiency virus 1 protease using a set of systematically altered peptide substrates. J Biol Chem 267, 9491-9498
40. 2, and αβ enzyme forms. J Biol Chem 252: 2290-2295
41. Ho D, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M (1995) Rapid turnover of plasma virons and CD4 lymphocytes in HIV-1 infection Nature 373: 123-126
42. Höglund S, Öfverstedt L-G, Nilsson A, Lundquist P, Gelderblom H, Özel M, Skoglund U (1992) Spatial visualization of the maturing HIV-1 core and its linkage to the envelope. AIDS Res Hum Retroviruses 8: 1-7
43. Hostomsky Z, Hostomska Z, Fu T-B, Taylor J (1992) Reverse transcriptase of human immunodeficiency virus type 1: functionality of subunits of the heterodimer in DNA synthesis J. Virol 66 3179-3182
44. Hrusková-Heidingsfeldová O, Andreansky M, Fabry M, Blaha I, Strop P, Hunter E (1995) Cloning, bacterial expression and characterization of the Mason-Pfizer monkey virus proteinase J Biol Chem 270: 15053-15058
45. Jacks T, Varmus HE (1985) Expression of the Rous sarcoma virus pol gene by ribosomal frameshifting. Science 230. 1237-1242
46. Jacobo-Molina A, Ding J, Nanni R, Clark AD, Lu X, Tantillo C, Williams RL, Kamer G, Ferris AL, Clark P, Hizi A, Hughes SH, Arnold E (1993) Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double stranded DNA at 3.0 Å resolution shows bent DNA Proc Natl Acad Sci USA 90: 6320-6324
47. Jacobsen H, Ahlborn-Laake L, Gugel R, Mous J (1992) Progression of early steps of human immunodeficiency virus type 1 replication in the presence of an inhibitor of viral protease J Virol 66: 5087-5091
48. James MNG, Sielecki AR (1986) Molecular structure of an aspartic proteinase zymogen, porcine pepsinogen, at 1 8 Å resolution. Nature 319 33-38.
49. Jaskólski M, Miller M, Rao JKM, Leis J, Wlodawer A (1990) Structure of the aspartic protease from Rous sarcoma retrovirus refined at 1 Å resolution. Biochemistry 29: 5889-5898
50. Kaplan AH, Swanstrom R (1991) Human immunodeficiency virus type 1 Gag proteins are processed in two cellular compartments Proc Natl Acad Sci USA 88: 4528-4532
51. Kaplan AH, Zack JA, Knigge M, Paul DA, Kempf DJ, Norbeck DW, Swanstrom R (1993) Partial inhibition of the human immunodeficiency virus type 1 protease results in aberrant virus assembly and the formation of noninfectious particles. J Virol 67: 4050-4055
52. Kaplan AH, Krogstad P, Kempf DJ, Norbeck DW, Swanstrom R (1994a) Human immunodeficiency virus type 1 virions composed of unprocessed Gag and Gag-Pol precursors are capable of reverse transcribing viral genomic RNA. Antimicrobial Agents Chemotherapy 38: 2929-2933
53. Kaplan AH, Manchester M, Swanstrom R (1994b) The activity of the protease of human immunodeficiency virus type 1 is initiated at the membrane of infected cells before the release of viral proteins and is required for release to occur with maximum efficiency. J Virol 68: 6782-6786
54. Katoh I, Yoshinaka Y, Rein A, Shjibuya M, Adaka T, Oroszlan S (1985). Murine leukemia virus maturation protease region required for conversion from "immature" to "mature" core form and for virus infectivity. Virology 145: 280-292
55. Katz R A, Skalka AM (1988) A C-terminal domain in the avian sarcoma-leukosis virus pol gene product is not essential for viral replication J Virol 62. 528-533
56. Katz RA, Skalka AM (1994) The retroviral enzymes. In: Richardson CC (ed) Annual Review of Biochemistry, vol. 63 Annual Reviews, Palo Alto, pp 133-173
57. Kohl NE, Emini EA, Schleif WA, Davis LJ, Heimbach JC, Dixon RAF, Scolnick EM, Sigal IS (1988) Active human immunodeficiency virus protease is required for viral infectivity. Proc Natl Acad Sci USA 85: 4686-4690
58. Kohlstaedt LA, Wang J, Friedman JM, Rice PA, Steitz TA (1992) Crystal structure at 3.5 Å resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science 256: 1783-1790
59. Konvalinka J, Horejsi M, Andreansky M, Novek P, Pichova I, Blaha I, Fabry M, Sedlacek J, Foundling S, Strop P (1992) An engineered retroviral proteinase from myeloblastosis associated virus acquires pH dependence and substrate specificity of the HIV-1 proteinase. EMBO J 11: 1141-1144
60. Konvalinka J, Heuser AM, Hruskova-Heidingsfeldova O, Vogt VM, Sedlacek J, Strop P, Kräusslich HG (1995a) Proteolytic processing of particle-associated retroviral polyproteins by homologous and heterologous viral proteinases Eur J Biochem 228: 191-198
61. Konvalinka J, Litterst MA, Welker R, Rippmann R, Heuser A-M, Kräussfich HG (1995b) HIV-1 protease (PR) active site mutation causes reduced PR activity and loss of PR-mediated cytotoxicity without apparent effect on virus maturation and infectivity J Virol 69: 7180-7186
62. Konvalinka J, Loechelt M, Zentgraf H, Fluegel RM, Kräusshch H-G (1995c) Active foamy virus proteinase is required for virus infectivity but not for formation of a Pol potyprotein. J Virol 69: 7264-7268
63. Korb J, Trávnícek M, Ríman J (1976) The oncornavirus maturation process, quantitative correlation between morphological changes and conversion of genomic virion RNA Intervirology 7. 211-224
64. Kotler M, Arad G, Hughes SH (1992) Human immunodeficiency virus type 1 Gag-protease fusion proteins are enzymatically active. J Virol 66: 6781-6783
65. Kottler H, Weber J, Konvalinka J, Kräusslich H-G (1995) A mutation in HIV-1 proteinase gives rise to a virus temperature-sensitive for polyprotein processing and for viral infectivity (manuscript in preparation)
66. Kräusslich HG (1991) Human immunodeficiency virus proteinase dimer as a component of the viral polyprotein prevents particle assembly and viral infectivity Proc Natl Acad Sci USA 88: 3213-3217
67. Kräusslich HG (1992) Specific inhibitor of human immunodeficiency virus proteinase prevents the cytotoxic effects of a single-chain proteinase dimer and restores particle formation. J Virol 66. 567-572
68. Kräusslich HG, Wimmer E (1988) Viral proteinases Annu Rev Biochem 57: 701-754
69. Kräusslich HG, Schneider H, Zybarth G, Carter CA, Wimmer E (1988) Processing of in vitro-synthesized Gag precursor proteins of human immunodeficiency virus HIV type 1 by HIV proteinase generated in Escherichia coli. J Virol 62: 4393-4397
70. Kräusslich HG , Ingraham RH, Skoog MT, Wimmer E, Pallai PV, Carter (1989) Activity of purified biosynthetic proteinase of human immunodeficiency virus on natural substrates and synthetic peptides Proc Nat Acad Sci USA 86. 807-811
71. Kräusslich HG, Fäcke M, Heuser AM, Konvalinka J, Zentgraf W (1995) The spacer peptide between human immunodeficiency virus capsid and nucleocapsid proteins is essential for ordered assembly and viral infectivity J Virol 69: 3407-3419
72. Kuff EL, Lueders KK (1988) The intracisternal A particle gene family: structure and functional aspects Adv Cancer Res 51: 183-276
73. Lapatto R, Blundell T, Hemmings A, Overington J, Wilderspin A, Wood S, Merson JR, Whittle PJ, Danley DE, Geoghegan KF, Hawryklik SJ, Lee SE, Scheid KG, Hobart PM (1989) X-ray analysis of HIV-1 proteinase at 2 7 Å resolution confirms structural homology among retroviral enzymes Nature 342. 299-302
74. LeGrice SFJ, Naas T, Wohlgensinger B, Schatz O (1991) Subunit-selective mutagenesis indicates minimal polymerase activity in heterodimer associated p51 of HIV-1 reverse transcriptase EMBO J 10: 3905-3911
75. Loeb DD, Swanstrom RS, Everitt L, Manchester M, Stamper SE, Hutchison CA III (1989) Complete mutagenesis of the HIV-1 protease. Nature 340. 397-400
76. Louis JM, Nashed NT, Parris KD, Kimmel AR, Jerina DM (1994) Kinetics and mechanism of autoprocessing of human immunodeficiency virus type 1 protease from an analog of the Gag-Pol polyprotein. Proc Natl Acad Sci USA 91. 7970-7974
77. Luftig RB, Yoshinaka Y (1978) Rauscher leukemia virus populations enriched for "immature" virions contain increased amounts of P70, the gag gene product. J Virol 25. 416-421
78. Manchester M, Everitt L, Loeb DD, Hutchison CAIII, Swanstrom R (1994) Identification of temperature-sensitive mutants of the human immunodeficiency virus type 1 protease through saturation mutagenesis: amino acid side chain requirements for temperature sensitivity. J Biol Chem 269: 7689-7695
79. Mervis RJ, Ahmad N, Lillehoj EP, Raum MG, Salazar FHR, Chan HW, Venkatesan S (1988) The gag gene products of human immunodeficiency virus type 1. Alignment within the gag open reading frame, identification of posttranslational modifications, and evidence for alternative gag precursors J Virol 62. 3993-4002
80. Miller M, Schneider J, Sathyanarayana BK, Toth MV, Marchall GR, Clawson L, Selk L, Kent SBH, Wlodawer A (1989) Structure of complex of synthetic HIV-1 protease with a substrate based inhibitor at 2.3 Å resolution. Science 246 1149-1152
81. Moody MD, Pettit SC, Shao W, Everitt L, Loeb DD, Hutchison CA III, Swanstrom R (1995) A side chain at position 48 of the human immunodeficiency virus type-1 protease flap provides an additional specificity determinant. Virology 207: 475-485
82. Nagy K, Young M, Baboonian C, Merson J, Whittle P, Oroszlan S (1994) Antiviral activity of human immunodeficiency virus type 1 protease inhibitors in a single cycle of infection: evidence for a role of protease in the early phase J Virol 68: 757-765
83. Navia MA, Fitzgerald PMD, McKeever BM, Leu C-T, Heimbach JC, Herber WK, Sigal IS, Darke PL, Springer JP (1989) Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1. Nature 337: 615-620
84. Nermut MV, Hockley DJ, Jowett JBM, Jones IM, Garreau M, Thomas D (1994) Fullerene-like organization of HIV gag protein shell in virus-like particles produced by recombinant baculovirus. Virology 198. 288-296
85. Nicholson LK, Yamazaki T, Torchia DA, Grzesiek S, Bax A, Stahl SJ, Kaufman JD, Wingfield PT, Lam PYS, Jadhav PK, Hodge CN, Domaille PJ, Chang CH (1995) Flexibility and function in HIV-1 protease Nature Struct Biol 2: 274-280
86. Oertle S, Spahr P-F (1990) Role of the Gag polyprotein precursor in packaging and maturation of Rous sarcoma virus genomic RNA. J Virol 64 5757-5763
87. Oertle S, Bowles N, Spahr P-F (1992) Complementation studies with RSV Gag and Gag-Pol polyprotein mutants J Virol 66. 3873-3878
88. Oppermann H, Bishop JM, Varmus HE, Levintow L (1977) A joint product of the genes gag and pol of avian sarcoma virus: a possible precursor of reverse transcriptase Cell 12. 993-1005
89. Otto MJ, Garber S, Winslow DL, Reid CD, Aldrich P, Jadhar PK, Patterson CE, Hodge CN, Cheng Y-SE (1993) In vitro isolation and identification of human immunodeficiency virus (HIV) variant with reduced sensitivity to C-2 symmetrical inhibitors of HIV type 1 protease. Proc Natl Acad Sci USA 90: 7543-7547
90. Parent LJ, Bennett RP, Craven RC, Nelle TD, Krishna NK, Bowzard JB, Wilson CB, Puffer BA, Montelaro RC, Wills JW (1995) Positionally independent and exchangeable late budding functions of the RSV and HIV Gag proteins. J Virol 69
91. Peng C, Ho BK, Chang TW, Chang NT (1989) Role of human immunodeficiency virus type 1-specific protease in core protein maturation and viral infectivity. J Virol 63. 2550-2556
92. Peng C, Chang NT, Chang TW (1991) Identification and characterization of human immunodeficiency virus type 1 gag-pol fusion protein in transfected mammalian cells. J Virol 65: 2751-2756
93. Pepinsky RB (1983) Localization of lipid-protein and protein-protein interactions within the murine retrovirus gag precursor by a novel peptide mapping technique. J Biol Chem 258: 11229-11235
94. Pepinsky RB, Papayannopoulos IA, Chow EP, Krishna NK, Craven RC, Vogt VM (1995) Differential proteolytic processing leads to multiple forms of the CA protein of avian sarcoma and leukemia viruses. J Virol 69: 6430-6438
95. Pepinsky RB, Papayannopoulos IA, Campbell S, Vogt VM (1996) Analysis of Rous sarcoma virus Gag proteins by mass spectrometry indicates trimming by host exopeptidase. J Virol 70. (in press)
96. Pettit SC, Simsic J, Loeb DD, Everitt L, Hutchison CA III, Swanstrom R (1991) Analysis of retroviral protease cleavage sites reveals two types of cleavage sites and the structural requirements of the P1 amino acid. J Biol Chem 266: 14539-14547
97. Pettit SC, Moody MD, Wehbie RS, Kaplan AH, Nantermet PV, Klein CA, Swanstrom R (1994) The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions. J Virol 68. 8017-8027
98. Pichova I, Strop P, Sedlacek J, Kapralek F, Benes V, Travnicek M, Pavlickova L, Soujcek M, Kostka V, Foundling S (1992) Isolation and biochemical characterization and crystallizaton of the p15Gag proteinase of myeloblastosis associated virus expressed in E. coli. Int J Biochem 24: 235-242
99. Pinter A, DeHarven E (1979) Protein composition of a defective murine sarcoma virus particle possessing the enveloped Type-A morphology. Virology 99: 103-110
100. Phylip LH, Mills JS, Parten BF, Dunn BM, Kay J (1992) Intrinsic activity of precursor forms of HIV-1 proteinase. FEBS Lett 314: 449-454
101. Poorman RA, Tomasselli AG, Heinrikson RL, Kézdy FJ (1991) A cumulative specificity model for proteases from human immunodeficiency virus types 1 and 2, inferred from statistical analysis of an extended substrate data base J Biol Chem 266: 14554-14561
102. Prats A-C, Sarin L, Gabus C, Litvak S, Keith G, Darlix J-L (1988) Small finger protein of avian and murine retroviruses has nucleic acid annealing activity and positions the replication primer tRNA onto genomic RNA. EMBO J. 7 1777-1783
103. Rao JKM, Erickson JW, Wlodawer A (1991) Structural and evolutionary relationships between retroviral and eucaryotic aspartic proteinases Biochemistry 30: 4663-4671
104. Rein A, McClure MR, Rice NR, Luftig RB, Schultz AM (1986) Myristylation site in Pr65gag is essential for virus particle formation by Moloney murine leukemia virus. Proc Nat Acad Sci USA 83: 7246-7250
105. Rein A, Mirro J, Haynes JG, Ernst SM, Nagashima K (1994) Function of the cytoplasmic domain of a retroviral transmembrane protein. p15E-p12E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein. J Virol 68: 1773-1781
106. Restle T, Mueller B, Goody RS (1990) Dimerization of human immunodeficiency virus type 1 reverse transcriptase. J Biol Chem 265: 8986-8988
107. Rhee SS, Hunter E (1987) Myristylation is required for intracellular transport but not for assembly of D-type retrovirus capsids J Virol 61: 1046-1053
108. Rice NR, Henderson LE, Sowder RC, Copeland TD, Oroszlan S, Edwards JF (1990) Synthesis and processing of the transmembrane envelope protein of equine infectious anemia virus. J. Virol 64. 3770-3778
109. Ringe D (1994) X-ray structures of retroviral proteases and their inhibitor-bound complexes. In: Kuo LC, Shafer JA (eds) Retroviral proteases. Academic, New York, pp 157-177 (Methods in enzymology, vol 241)
110. Riviere Y, Blank R, Kourilsky P, Israel I (1991) Processing of the precursor of NK-keppa B by the HIV-1 protease during acute infection Nature 350: 625-626
111. Roberts MM, Copeland TD, Oroszlan S (1991) In situ processing of a retroviral nucleocapsid protein by the viral proteinase Protein Eng 4: 695-700
112. Rosé JR, Salto R, Craik CS (1993) Regulation of autoproteolysis of the HIV-1 and HIV-2 proteases with engineered amino acid substitutions. J Biol Chem 268: 11939-11945
113. Rosé JR, Babé LM, Craik CS (1995) Defining the level of human immunodeficieincy virus type 1 (HIV-1) protease activity required for HIV1 particle maturation and infectivity. J Virol 69: 2751-2758
114. Schatz G, Pichova I, Vogt VM (1996) Cleavage and miscleavage at the mutant and wild type NC-PR junction in avian sarcoma and leukemia viruses (manuscript in preparation)
115. Sellos-Moura M, Vogt VM (1995) Proteolytic activity of the NC-PR fragment of avian sarcoma and leukemia virus Gag protein purified from E. coli. Virology (in press)
116. Sheng N, Erickson-Viitanen S (1994) Cleavage of p15 protein in vitro by human immunodeficiency virus type 1 protease is RNA dependent. J Virol 68: 6207-6214
117. Shoeman RL, Honer B, Stoller TJ, Kesselmeier C, Miedel MC, Traub P, Graves MC (1990) Human immunodeficiency virus-1 protease cleaves the intermediate filament proteins vimentin, desmin, and glial fibrillary acidic protein. Proc Natl Acad Sci USA 87: 6636-6340
118. Skalka AM (1989) Retroviral proteases: a first glimpse at the anatomy of a processing machine. Cell 56: 911-913
119. Soltis DA, Skalka AM (1988) The áand β chains of avian retrovirus reverse transcriptase independently expressed in E. coli. characterization of enzymatic activities Proc Natl Acad Sci USA 85: 3372-3376
120. Sonigo P, Barker C, Hunter E, Wain-Hobson S (1986) Nucleotide sequence of Mason-Pfizer monkey virus, an immunosuppressive type D retrovirous Cell 45: 373-386
121. Sommerfelt MA, Petteway JR, Dreyer GB, Hunter E (1992) Effect of retroviral proteinase inhibitors on Mason-Pfizer monkey virus maturation and transmembrane protein cleavage. J Virol 66: 4220-4227
122. Stewart L, Vogt VM (1991) Trans-acting viral protease is necessary and sufficient for activation of avian leukosis virus reverse transcriptase J Virol 65: 6218-6231
123. Stewart L, Vogt VM (1993) Reverse transcriptase and protease activities of avian leukosis virus Gag-Pol fusion proteins expressed in insect cells. J Virol 67: 7582-7596
124. Stewart L, Vogt VM (1994) Proteotytic cleavage at the Gag-Pol junction in avian leukosis viruses: differences in vitro and in vivo. Virology 204: 45-59
125. Stewart L, Schatz G, Vogt VM (1990) Properties of avian retrovirus particles defective in viral protease. J Virol 64: 5076-5092
126. Stromberg K, Hurley NE, Davis NL, Rueckert RR, Fleissner E (1974) Structural studies of avian myeloblastosis virus: comparison of polypeptides in virion and core component by dodecyl sulfatepotyacrylamide gel electrophoresis. J Virol 13: 513-528
127. Telesnitsky A, Goff SP (1993) RNase H domain mutations affect the interaction between Moloney murine leukemia virus reverse transcriptase and its primer-template Proc Natl Acad Sci USA 90, 1276-1280
128. Toh H, Ono M, Saigo K, Miyata T (1985) Retroviral protease-like sequence in the yeast transposon Ty1. Nature 315 691-692
129. Tomasselii AG, Heindrikson RL (1994) Specificity in retroviral protease an analysis of viral and non-viral protein substrates. In: Kuo LC, Shafer JA (eds) Retroviral proteases. Academic, New York, pp 279-301 (Methods in enzymology, vol 241)
130. Tomasselii AG, Hui JO, Adams L, Chosay J, Lowery D, Greenberg B, Yem A, Deibel MR, Zurcher-Neely H, Heinrikson RL (1991) Actin, troponin c, Alzheimer amyloid precursor protein, and prointerleukin 1-beta as substrates of the protease from human immunodeficiency virus. J Biol Chem 266: 14548-14553.
131. Tözsér, Weber IT, Gustchina A, Bláha In, Copeland TD, Louis JM, Oroszlan S (1992) Kinetic and modeling studies of S3-S3′, subsites of HIV protemases. Biochemistry 31: 4793-4800
132. Tritch RJ, Cheng YS, Yin FH, Erickson-Viitanen S (1991) Mutagenesis of protease cleavage sites in the human immunodeficiency virus type 1 gag polyprotein J Virol 65: 922-930
133. Valverde V, Lemay P, Masson JM, Gay B, Boulanger P (1992) Autoprocessing of the human immunodeficiency virus type 1 protease precursor expressed in Escherichia coli from a synthetic gene J Gen Virol 73: 639-651
134. Vogt VM, Eisenman R (1973) Identification of a large polypeptide precursor of avian oncornavirus proteins. Proc Natl Acad Sci USA 70 1734-1738
135. Vogt VM, Eisenman R, Diggelmann H (1975) Generation of avian myeloblastosis virus structural proteins by proteolytic cleavage of a precursor polypeptide. J Mol Biol 96. 471-493
136. Vogt VM, Burstein H, Skalka AM (1992) Proteotysis in the maturation of avian retroviruses does not require calcium. Virology 189 771-774
137. von der Helm K (1977) Cleavage of Rous sarcoma viral polypeptide precursor into internal structural proteins in vitro involves viral protein p15 Proc Natl Acad Sci USA 74: 911-915
138. Wallin M, Deinum J, Goobar L, Danielson UH (1991) Proteolytic cleavage of microtubule associated proteins by retroviral proteinases. J Gen Virol 71. 1985-1992
139. Weber IT, Miller M, Jaskolski M, Leis J, Skalka AM, Wlodawer A (1989) Molecular modeling of the HIV-1 protease and its substrate binding site Science 243: 928-931
140. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson JD, Bonhoeffer S, Nowak M, Hahn BH, Saag MS, Shaw GM (1995) Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373: 117-122
141. Welker R, Janetzko A, Heuser A-M, Kràusslich H-G (1995) Targeting of intracisternal A-type particle Gag polyprotein to the plasma membrane leads to release of extracellular particles and induces polyprotein processing (submitted for publication)
142. Wills JW, Craven RC (1991) Form function and use of retroviral Gag proteins AIDS (Phil) 5: 639-654
143. Wills JW, Craven RC, Achacoso JA (1989) Creation and expression of myristylated forms of Rous sarcom virus Gag protein in mammalian cells. J Virol 55: 79-85
144. src. J Virol 65: 3804-3812
145. Wills JW, Cameron CE, Wilson CB, Xiang Y, Bennett RP, Leis J (1994) An assembly domain of the Rous sarcoma virus Gag protein required late in budding J Virol 68 6605-6618
146. Wlodawer A, Erickson JW (1993) Structure-based inhibitors of HIV-1 protease. In: Richardson CC (ed) Annual review of biochemistry, vol 62, Annual Reviews, Palo Alto, pp 543-585
147. Wlodawer A, Miller M, Jaskólski M, Sathyanarayana BK, Baldwin E, Weber IT, Selk LM, Clawson L, Schneider J, Kent SBH (1989) Conserved folding in retroviral proteases crystal structure of a synthetic HIV1 protease. Science 245: 616-621
148. Wondrak EM, Sakaguchi K, Rice WG, Kun E, Kimmel AR, Louis JM (1994) Removal of zinc is required for processing of the mature nucleocapsid protein of human immunodeficiency virus, type1, by the viral protease. J Biol Chem 269. 21948-21950
149. Yoshinaka Y, Luftig RB (1977) Murine leukemia virus morphogenesis: cleavage of P70 in vitro can be accompanied by a shift from a concentrically coiled internal strand ("immature") to a collapsed ("mature") form of the virus core. Proc Natl Acad Sci USA 74: 3446-3450
150. Yu SF, Baldwin DN, Gwynn SR, Yendapalli S, Linial ML (1996) Human foamy virus replication: A pathway distinct from that of retroviruses and hepadnaviruses. Science 271: 1579-1582
151. Zhang ZY, Poorman RA, Maggiora LL, Heinrikson RL, Kezdy FJ (1991) Dissociative inhibition of dimeric enzymes kinetic characterization of the inhibition of HIV-1 protease by its carboxyl terminal tetrapeptide J Biol Chem 266:15591-15594
152. Zhang D, Zhang N, Wick MM, Byrn RA (1995) HIV type 1 protease activation of NF-kappa-B within T lymphoid cells. AIDS Res and Hum Retroviruses 11. 223-230
153. Zybarth G, Carter C (1995) Domains upstream of the protease (PR) in human immunodeficiency virus type 1 Gag-Pol influence PR autoprocessing J Virol 69: 3878-3884
154. Zybarth G, Kräusslich HG, Partin K, Carter C (1994) Proteolytic activity of novel human immunodeficiency virus type 1 proteinase proteins from a precursor with a blocking mutation at the N terminus of the PR domain J Virol 68: 240-250